• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—Dec. 9

    Babson Diagnostics’ BetterWay Achieves Regulatory Milestone

    WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study

    Everly Health Releases At-Home Collection Kidney Health Test

    Kenco Adds Two to its Life Sciences Division Team
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    A Peek Into the 2028 MPO Summit

    Retail Healthcare Disruptors and Medical Devices

    Six Developments Your Talent Strategy Should Prepare for in 2024

    The Power and Paradox of Never

    Navigating the Q-Sub Program: How Experienced Lab Partners Can Help Streamline Regulatory Submission
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    BMP Medical

    Arthur G Russell Company, The

    JBC Technologies

    Poly-Med, Inc.

    Cirtec Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Telemedicine for Neurology: 5 Benefits of Remote Management

    Machining 101: A Review of Machining Components with a Five-Axis System

    MedTech 2024: Top 5 Trends Shaping a Dynamic Industry

    Early Warning: A Q&A with Abbott's CMO of Heart Failure

    2023 in Review: Medtech's Mega-M&A Is MIA
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    BMP Medical

    Arthur G Russell Company, The

    JBC Technologies

    Poly-Med, Inc.

    Cirtec Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Software Validation: How It Should Be Done

    With vague guidance from FDA, device makers need to ensure they are using best practices.

    Software Validation: How It Should Be Done
    Erin Wright, Validation Product Manager, MasterControl04.26.18
    Software validation—the mere mention of it is enough to give a quality, IT, or validation professional a sinking feeling, if not a headache. Why? Because as most who have done it know, it can be one of the most resource-intensive, time-consuming, and costly compliance activities for regulated companies.
     
    Under 21 CFR Part 11, organizations that operate under the auspices of the U.S. Food and Drug Administration (FDA) are required to validate electronic systems that create, modify, maintain, archive, retrieve, or transmit electronic records required by predicate regulations. Medical device firms must also comply with 21 CFR 820, a predicate rule that similarly requires software validation.
     
    The perennial and problematic challenge comes from the fact that while the FDA requires validation, it does not specify how companies should go about the validation process. What the FDA wants is evidence that a company has documented how it intends to conduct validation and prove that it has done it the way it said it would. The objective of validation is to ensure the software will work as expected and specified. So, the question remains, “How do you conduct validation properly and successfully?”
     
    In its guidance on “Part 11, Electronic Records; Electronic Signatures—Scope and Application,” the FDA states, “We suggest that your decision to validate computerized systems, and the extent of the validation, take into account the impact the systems have on your ability to meet predicate rule requirements. You should also consider the impact those systems might have on the accuracy, reliability, integrity, availability, and authenticity of required records and signatures. Even if there is no predicate rule requirement to validate a system, in some instances it may still be important to validate the system.” In addition, the agency recommends that companies base their approach on a justified and documented risk assessment.
     
    This doesn’t give much in the way of specific direction. As such, most companies are left erring on the side of caution when it comes to validation, and they validate much more than is necessary. The result is a validation process that takes months to accomplish. This often delays an organization’s ability to go live with new software or upgrade existing software. This causes the company to work with out-of-date software that can hinder its ability to optimize processes and stay up to date on the most recent security updates and other features.

    Best Approach to Software Validation
    In the Part 11 guidance, the FDA alludes that taking a risk-based approach cuts down the time it takes to conduct validation. Risk assessment is the key. Validation is a process that helps ensure life science companies are doing what they need to do to remove or mitigate risk. In fact, the argument can be made that most regulations are in place to remove risk along the product lifecycle, from the design and development through the use by consumers. A current trend among software suppliers, particularly those that create cloud-based software, is to provide their users with “canned” validation methodologies or scripts that are intended to cut time for the user. It is a step in the right direction, but it is not enough and can even put users at greater risk.
     
    A simplified example in such a scenario would be a supplier providing a risk assessment for the software stating that “exporting a document is low risk.” Again, this is not enough and may introduce risk for the company because it all depends on how the software is actually used, not necessarily on how the supplier intended it to be used.
     
    For instance, exporting documents may be low risk as a software feature, but if those documents are intended for regulatory submission, it suddenly increases the risk of the software to the company because of how it’s using the software. Another company may just export documents to a desktop for the purpose of sending those documents to employees via email. It’s the same software functionality, but a significantly different impact of failure for each company. This is why regulated companies can’t rely on supplier software risk assessments alone, since suppliers can’t take into account a company’s business practices.
     
    It’s important to leverage the supplier validation documentation, but it can’t be the only step of the risk assessment. Risk must be assessed by functionality and usage, not just one or the other. A properly executed risk assessment will focus on the user’s critical business processes (CBPs), not just on the software.
     
    Once risk assessments for individual CBPs have been determined, a validation approach for each area can be conducted. The following best-practice approach outlines three types of validations that can be utilized with a risk-based process. 
     
    1. High: Complete/comprehensive testing required. All usage scenarios must be thoroughly tested. This is similar to the “traditional” approach to validation.
    2. Medium: Testing of the functional requirements per the CBPs required with sufficient assurance that each item has been properly characterized.
    3. Low: No formal testing needed.
     
    If a company understands its true risk of software adoption based on its CBPs, validation no longer needs to be an all-or-nothing activity. It can be done with surgical precision, cutting down the validation time from months to days or even hours. Companies can leverage their suppliers’ documentation, but they must properly assess their own software usage in relation to their regulatory requirements.
     

    Erin Wright, MasterControl’s validation product manager, spearheads the efforts pertaining to the development of the company’s Validation Excellence Tool (VxT), which streamlines the risk-assessment process and greatly reduces validation time. She joined MasterControl in 2013 as a professional services consultant and worked closely with hundreds of regulated companies, including the FDA’s Center for Drug Evaluation and Research (CDER), Ancestry.com, Abbott Point of Care, Institute for Transfusion Medicine (ITxM), and the University of Utah, in conducting custom validation implementations. Her extensive experience in quality, validation, and regulatory compliance includes working for an automated-testing software company and several clinical-trial software providers. She graduated summa cum laude from West Chester University with a degree in psychology.
    Related Searches
    • u.s. food and drug administration
    • institute
    • surgical
    • security
    Related Knowledge Center
    • Software & IT
      Loading, Please Wait..

      Breaking News
      • MPO's Most-Read Stories This Week—Dec. 9
      • Babson Diagnostics’ BetterWay Achieves Regulatory Milestone
      • WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study
      • Everly Health Releases At-Home Collection Kidney Health Test
      • Kenco Adds Two to its Life Sciences Division Team
      View Breaking News >
      CURRENT ISSUE

      November 2023

      • MPO's 2023 Medical Device Industry Year in Review
      • The Beat Goes On in the Cardiovascular Device Market
      • Medical Manufacturers Gain Support from 3D Printing
      • The Intelligent Tools Medical Device Manufacturers Already Own
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Women in Nutraceuticals Hires Executive Director Rebecca Takemoto
      FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition
      MSM Linked to Improvements in Knee Pain
      Coatings World

      Latest Breaking News From Coatings World

      Weekly Recap: PPG, PPG Asian Paints, AkzoNobel Top This Week’s Stories
      Orion S.A. Has Four Carbon Black Plants Awarded ISCC PLUS
      Peninsula Polymers Acquires New Distribution Center in Indiana
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      MPO's Most-Read Stories This Week—Dec. 9
      Babson Diagnostics’ BetterWay Achieves Regulatory Milestone
      WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study
      Contract Pharma

      Latest Breaking News From Contract Pharma

      FDA Approves Bio-Thera's Biosimilar Referencing Roche’s Avastin
      Full-Life Technologies to Build GMP Radiopharmaceuticals Mfg. Facility
      Innovent Biologics, Synaffix Expand ADC Licensing Deal
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      COSRX’s Latest TikTok Campaign Accumulates 3.2B Views on TikTok
      Christian Louboutin Taps Morgane Martini as Global Makeup Artist
      Shiseido Forms New Venture Fund
      Happi

      Latest Breaking News From Happi

      Diya Beauty & Wellness Acquires WR Group's Retail Brands and North American Sales Division
      Pantone Color of the Year & A New CEO
      When It Comes to Bath and Body Rituals, Consumers Want The Works
      Ink World

      Latest Breaking News From Ink World

      Weekly Recap: Siegwerk, DIC, and Müller Martini Top This Week’s Stories
      Orion S.A. Now Has Four Carbon Black Plants Awarded ISCC PLUS
      BASF Commits to Scope 3.1 Emissions Targets
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Analyzing the Russian label market, Carter boosts brands and more
      FLAG’s December Lunch & Learn to feature Omet
      UPM Raflatac releases neuromarketing study findings
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Weekly Recap: New Dates for INDEX 26, Campen Announces Patent Pending Status for Airlaid Trays
      Ginni Strikes Deal to Sell Spinning, Knitting Operations
      Campen Machinery Announces Patent Pending Status for Airlaid Trays
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      ODT's Most-Read Stories This Week—Dec. 9
      Fujitsu, iSurgery Launch Bone Health Promotion Project in Japan
      Wenzel Spine Hires Dr. Robert Gordon as Executive Chairman
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Weekly Recap: Schreiner MediPharm, GIANCE and PragmatIC Top This Week’s Stories
      Intel CEO Pat Gelsinger to Cover AI During CES 2024 Keynote
      Ciena Invests in US Manufacturing with Flex

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login